Table 2.
[Japan] | |||||||
---|---|---|---|---|---|---|---|
Variables | HPV 16 | HPV cocktail | |||||
Positive (n=29) | Negative (n=11) | p | Positive (HPV 16 (–)) (n=5) | Negative (n=6) | p | ||
Age group (years) | |||||||
25–40 | 8 | 3 | 2 | 1 | |||
41–56 | 12 | 8 | NS | 3 | 4 | NS | |
≥57 | 9 | 0 | 0 | 1 | |||
No of pregnancies | |||||||
1–2 | 10 | 4 | 2 | 1 | |||
3–5 | 15 | 7 | NS | 3 | 5 | NS | |
≥6 | 4 | 0 | 0 | 0 | |||
No of parities | |||||||
0 | 2 | 1 | 1 | 0 | |||
1–2 | 16 | 6 | NS | 2 | 2 | NS | |
3–5 | 10 | 4 | 2 | 4 | |||
≥6 | 1 | 0 | 0 | 0 | |||
Histological type | |||||||
ACC | 3 | 9 | <0.0001 | 4 | 5 | NS | |
SCC | 26 | 2 | 1 | 1 | |||
Stage I/II | 20 | 11 | 0.0433 | 5 | 6 | NS | |
III/IV | 9 | 0 | 0 | 0 |
[Mongolia] | |||||||
---|---|---|---|---|---|---|---|
Variables | HPV 16 | HPV cocktail | |||||
Positive (n=21) | Negative (n=11) | p | Positive (HPV 16 (–)) (n=8) | Negative (n=3) | p | ||
Age group (years) | |||||||
25–40 | 7 | 4 | NS | 3 | 1 | ||
41–56 | 13 | 5 | 4 | 1 | NS | ||
≥57 | 1 | 2 | 1 | 1 | |||
No of pregnancies | |||||||
1–2 | 2 | 4 | 2 | 2 | |||
3–5 | 10 | 2 | NS | 2 | 0 | NS | |
≥6 | 9 | 5 | 4 | 1 | |||
No of parities | |||||||
0 | 0 | 1 | 0 | 1 | |||
1–2 | 9 | 4 | NS | 3 | 1 | NS | |
3–5 | 7 | 4 | 3 | 1 | |||
≥6 | 5 | 2 | 2 | 0 | |||
Histological type | |||||||
ACC | 0 | 4 | 0.0092 | 1 | 3 | 0.0242 | |
SCC | 21 | 7 | 7 | 0 | |||
Stage I/II | 16 | 7 | NS | 4 | 3 | NS | |
III/IV | 5 | 4 | 4 | 0 |
[Myanmar] | |||||||
---|---|---|---|---|---|---|---|
Variables | HPV 16 | HPV cocktail | |||||
Positive (n=15) | Negative (n=15) | p | Positive (HPV 16 (–)) (n=7) | Negative (n=8) | p | ||
Age group (years) | |||||||
25–40 | 6 | 1 | 1 | 0 | |||
41–56 | 3 | 13 | 0.0012 | 4 | 8 | NS | |
≥57 | 6 | 1 | 2 | 0 | |||
No of pregnancies | |||||||
1–2 | 2 | 2 | 1 | 1 | |||
3–5 | 7 | 6 | NS | 1 | 5 | NS | |
≥6 | 6 | 7 | 5 | 2 | |||
No of parities | |||||||
0 | 0 | 0 | 0 | 0 | |||
1–2 | 3 | 3 | NS | 2 | 1 | NS | |
3–5 | 11 | 8 | 2 | 6 | |||
≥6 | 1 | 4 | 3 | 1 | |||
Histological type | |||||||
ACC | 0 | 6 | 0.0169 | 4 | 2 | NS | |
SCC | 15 | 9 | 3 | 6 | |||
Stage I/II | 14 | 11 | NS | 6 | 5 | NS | |
III/IV | 1 | 4 | 1 | 3 |
SCC, squamous cell carcinoma; ACC, adenocarcinoma.